Free Trial

Pixie Dust Technologies (PXDT) Competitors

Pixie Dust Technologies logo
$0.58 +0.05 (+9.44%)
(As of 11/15/2024 ET)

PXDT vs. CODX, POCI, BSGM, SURG, IRIX, DRIO, MDAI, XAIR, ALUR, and NRXS

Should you be buying Pixie Dust Technologies stock or one of its competitors? The main competitors of Pixie Dust Technologies include Co-Diagnostics (CODX), Precision Optics (POCI), BioSig Technologies (BSGM), SurgePays (SURG), IRIDEX (IRIX), DarioHealth (DRIO), Spectral AI (MDAI), Beyond Air (XAIR), Allurion Technologies (ALUR), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry.

Pixie Dust Technologies vs.

Pixie Dust Technologies (NASDAQ:PXDT) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

In the previous week, Co-Diagnostics had 6 more articles in the media than Pixie Dust Technologies. MarketBeat recorded 8 mentions for Co-Diagnostics and 2 mentions for Pixie Dust Technologies. Co-Diagnostics' average media sentiment score of 0.73 beat Pixie Dust Technologies' score of 0.43 indicating that Co-Diagnostics is being referred to more favorably in the news media.

Company Overall Sentiment
Pixie Dust Technologies Neutral
Co-Diagnostics Positive

Pixie Dust Technologies has higher earnings, but lower revenue than Co-Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pixie Dust Technologies$6.30M1.37-$12.53MN/AN/A
Co-Diagnostics$6.81M4.97-$35.33M-$1.38-0.77

0.4% of Pixie Dust Technologies shares are owned by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are owned by institutional investors. 6.1% of Co-Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Co-Diagnostics received 272 more outperform votes than Pixie Dust Technologies when rated by MarketBeat users. However, 100.00% of users gave Pixie Dust Technologies an outperform vote while only 62.90% of users gave Co-Diagnostics an outperform vote.

CompanyUnderperformOutperform
Pixie Dust TechnologiesOutperform Votes
1
100.00%
Underperform Votes
No Votes
Co-DiagnosticsOutperform Votes
273
62.90%
Underperform Votes
161
37.10%

Pixie Dust Technologies presently has a consensus target price of $5.21, indicating a potential upside of 798.43%. Co-Diagnostics has a consensus target price of $1.50, indicating a potential upside of 41.51%. Given Pixie Dust Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Pixie Dust Technologies is more favorable than Co-Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pixie Dust Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Pixie Dust Technologies has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.84, suggesting that its stock price is 184% less volatile than the S&P 500.

Pixie Dust Technologies has a net margin of 0.00% compared to Co-Diagnostics' net margin of -563.93%. Pixie Dust Technologies' return on equity of 0.00% beat Co-Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Pixie Dust TechnologiesN/A N/A N/A
Co-Diagnostics -563.93%-54.94%-49.28%

Summary

Pixie Dust Technologies beats Co-Diagnostics on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PXDT vs. The Competition

MetricPixie Dust TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$8.62M$3.61B$5.17B$8.74B
Dividend YieldN/A1.65%5.18%4.08%
P/E RatioN/A13.3764.9214.18
Price / Sales1.3796.981,273.3887.02
Price / CashN/A46.1739.7935.24
Price / Book0.943.806.485.93
Net Income-$12.53M$92.21M$120.04M$225.73M
7 Day Performance26.07%-2.39%-5.13%-1.34%
1 Month Performance-63.76%13.84%-2.72%1.15%
1 Year Performance-92.90%26.34%31.17%24.02%

Pixie Dust Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXDT
Pixie Dust Technologies
2.1328 of 5 stars
$0.58
+9.4%
$5.21
+798.4%
-93.0%$8.62M$6.30M0.0078Short Interest ↑
High Trading Volume
CODX
Co-Diagnostics
4.41 of 5 stars
$1.06
-3.6%
N/A-24.0%$33.85M$6.81M-0.77100Short Interest ↓
Analyst Revision
POCI
Precision Optics
0.9151 of 5 stars
$5.23
+10.6%
N/A-12.1%$33.21M$19.10M-8.4480Short Interest ↓
News Coverage
Gap Up
BSGM
BioSig Technologies
N/A$1.82
+15.2%
N/A-48.6%$31.18M$20,000.000.0050News Coverage
Gap Up
SURG
SurgePays
3.8221 of 5 stars
$1.53
-6.1%
N/A-71.4%$30.85M$137.14M-1.3522Earnings Report
Short Interest ↓
News Coverage
Gap Down
IRIX
IRIDEX
0.7217 of 5 stars
$1.69
-4.5%
N/A-15.5%$28.12M$49.70M-2.52120Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
DRIO
DarioHealth
2.779 of 5 stars
$0.77
-4.9%
N/A-23.7%$26.29M$23.05M-0.82200Gap Down
MDAI
Spectral AI
2.8473 of 5 stars
$1.40
-3.4%
N/A-48.1%$25.92M$18.06M-2.1578
XAIR
Beyond Air
4.5016 of 5 stars
$0.50
-5.6%
N/A-68.2%$23.66M$1.16M-0.3670Earnings Report
Analyst Revision
News Coverage
ALUR
Allurion Technologies
2.1245 of 5 stars
$0.34
-14.9%
N/A-91.9%$22.08M$53.47M-0.71501Analyst Downgrade
Analyst Revision
News Coverage
High Trading Volume
NRXS
NeurAxis
N/A$3.15
-3.7%
N/A+23.0%$21.99M$2.46M-1.7119News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:PXDT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners